Repositioning FDA Drugs as Potential Cruzain Inhibitors from Trypanosoma cruzi: Virtual Screening, In Vitro and In Vivo Studies

por Palos, Isidro, Lara-Ramirez, Edgar E., Lopez-Cedillo, Julio Cesar, Garcia-Perez, Carlos, Kashif, Muhammad, Bocanegra-Garcia, Virgilio, Nogueda-Torres, Benjamin, Rivera, Gildardo
Publicado 2017